The proprietary NOVACAPS(TM) delivery system accommodates otherwise incompatible pharmaceutical agents, solid or liquid, in a single-dosage, combination product. Surging worldwide interest in such combination formats is evidenced by the FDA’s recent initiative to advance the development of single-dosage forms for delivery of multiple HIV/AIDS drugs.
